MGX Stock Analysis: Buy, Sell, or Hold?
MGX - Metagenomi, Inc. Common Stock
$1.23
0.00 (0.09%)
â˛
5d:
+0.09%
30d:
-0.72%
90d:
-6.02%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When MGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MGX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MGX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MGX is currently trading at $1.23, which is considered fair relative to its 30-day fair value range of $1.20 to $1.27.
Technical Outlook: Technically, MGX is in a strong downtrend. The price is approaching resistance at $1.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MGX scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+469.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MGX is in a strong downtrend. The price is approaching resistance at $1.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MGX scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+469.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.20 -
$1.27
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 469.1% below Wall St target ($7.00)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.20 -
$1.27
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.18
Resistance Level
$1.25
Current Trend
Strong Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.67
Wall Street Target
$7.00
(+469.1%)
Revenue Growth (YoY)
-69.8%
Share & Embed Analysis
Last updated: August 17, 2026 12:08 PM ET
Data refreshes hourly during market hours. Next update: 1:08 PM
Data refreshes hourly during market hours. Next update: 1:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Pamela Wapnick
SELL
1581 shares
2026-03-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$109 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 42 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 29 SELL |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 45 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
